Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 ...
TOKYO: Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the US firm's filing for such approval, the health minister said on Saturday .
Health Minister Katsunobu Kato's comment comes after remdesivir was granted emergency use authorisation by the US Food and Drug Administration for COVID-19 on Friday."I've heard that Gilead Sciences will file for approval within days," Kato told reporters."I issued an instruction so that we will be ready to approve it within a week or so.
The Nikkei business daily has said although Gilead planned to distribute enough doses to cover 140,000 patients worldwide, Japan would not receive enough for all its patients in need.Remdesivir, which previously failed as a treatment for Ebola, is being tried against COVID-19 because it is designed to disable the mechanism by which certain viruses, including the coronavirus, make copies of themselves and potentially overwhelm their host's immune system.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead aims to expand remdesivir output for COVID-19, posts flat first-quarter resultsGilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday reported flat first-quarter earnings and said it with ...
Read more »
COVID-19: Gilead to work with partners to ramp up production of drug remdesivirREUTERS: Gilead Sciences Inc, manufacturer of the experimental coronavirus drug remdesivir, on Thursday (Apr 30) said it will work with ...
Read more »
Singapore, Japan agree to deepen bilateral cooperation to fight Covid-19 pandemicTHE Ministry of Trade and Industry (MTI) and Japan's Ministry of Economy, Trade and Industry on Friday issued a joint statement agreeing to deepen bilateral economic cooperation to secure supply chains for essential goods and ensure that their economies stay resilient during the Covid-19 pandemic. Read more at The Business Times.
Read more »
Dr Noor Hisham: China medical experts impressed with Malaysia’s Covid-19 response, health facilitiesKUALA LUMPUR, May 1 — The team of medical experts from China lauded Malaysia for its quick and effective response to the coronavirus disease (Covid-19) including the enforcement of the movement...
Read more »
Mainland China reports one new COVID-19 caseBEIJING: China reported one new COVID-19 case on Friday (May 1), down from 12 a day earlier, data from the country’s health authority showed on ...
Read more »
Trump says tariffs on China 'certainly an option' as US COVID-19 death toll risesWASHINGTON: US President Donald Trump said on Friday (May 1) raising tariffs on China is 'certainly an option' as he considers ways to retaliate ...
Read more »